Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib

被引:5
作者
Robert, Marie [1 ]
Gallay, Laure [1 ]
Garnier, Lorna [2 ]
Pescarmona, Remi [2 ,3 ]
Hot, Arnaud [1 ]
机构
[1] Hosp Civils Lyon, Ctr Hospitalier Univ Edouard Herriot, Serv Med Interne & Immunol Clin, 5 Pl Arsonval, F-69437 Lyon, France
[2] Hosp Civils Lyon, Lab Immunol, Lyon, France
[3] Univ Claude Bernard, Univ Lyon, CNRS, Inserm,UMR 5308,U 1111,CIRI,Ctr Int Rech Infectiol, Lyon 1, F-69007 Lyon, France
关键词
Dermatomyositis; Calcinosis; Anti-NXP2; Interferon signature; JAK inhibitors;
D O I
10.1016/j.jbspin.2023.105532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 8 条
[1]   A child with severe juvenile dermatomyositis treated with ruxolitinib [J].
Aeschlimann, Florence A. ;
Fremond, Marie-Louise ;
Duffy, Darragh ;
Rice, Gillian I. ;
Charuel, Jean-Luc ;
Bondet, Vincent ;
Saire, Elsa ;
Neven, Benedicte ;
Bodemer, Christine ;
Balu, Laurent ;
Gitiaux, Cyril ;
Crow, Yanick J. ;
Bader-Meunier, Brigitte .
BRAIN, 2018, 141
[2]   Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases [J].
de Jesus, Adriana A. ;
Hou, Yangfeng ;
Brooks, Stephen ;
Malle, Louise ;
Biancotto, Angelique ;
Huang, Yan ;
Calvo, Katherine R. ;
Marrero, Bernadette ;
Moir, Susan ;
Oler, Andrew J. ;
Deng, Zuoming ;
Sanchez, Gina A. Montealegre ;
Ahmed, Amina ;
Allenspach, Eric ;
Arabshahi, Bita ;
Behrens, Edward ;
Benseler, Susanne ;
Bezrodnik, Liliana ;
Bout-Tabaku, Sharon ;
Brescia, AnneMarie C. ;
Brown, Diane ;
Burnham, Jon M. ;
Soledad Caldirola, Maria ;
Carrasco, Ruy ;
Chan, Alice Y. ;
Cimaz, Rolando ;
Dancey, Paul ;
Dare, Jason ;
DeGuzman, Marietta ;
Dimitriades, Victoria ;
Ferguson, Ian ;
Ferguson, Polly ;
Finn, Laura ;
Gattorno, Marco ;
Grom, Alexei A. ;
Hanson, Eric P. ;
Hashkes, Philip J. ;
Hedrich, Christian M. ;
Herzog, Ronit ;
Horneff, Gerd ;
Jerath, Rita ;
Kessler, Elizabeth ;
Kim, Hanna ;
Kingsbury, Daniel J. ;
Laxer, Ronald M. ;
Lee, Pui Y. ;
Lee-Kirsch, Min Ae ;
Lewandowski, Laura ;
Li, Suzanne ;
Lilleby, Vibke .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04) :1669-1682
[3]  
Fredi M, 2017, CLIN EXP RHEUMATOL, V35, P303
[4]   Mitochondrial STAT3: Powering up a potent factor [J].
Garama, Daniel J. ;
White, Christine L. ;
Balic, Jesse J. ;
Gough, Daniel J. .
CYTOKINE, 2016, 87 :20-25
[5]   Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China [J].
Li, Wendao ;
Wang, Wei ;
Zhong, Linqing ;
Gou, Lijuan ;
Wang, Changyan ;
Ma, Jingran ;
Quan, Meiying ;
Jian, Shan ;
Tang, Xiaoyan ;
Zhang, Yu ;
Wang, Lin ;
Ma, Mingsheng ;
Song, Hongmei .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[6]   Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis [J].
Mammen, Andrew L. .
NATURE REVIEWS NEUROLOGY, 2011, 7 (06) :343-354
[7]   JAK 1/2 Blockade in MDA5 Gain-of-Function [J].
McLellan, Kirsty E. ;
Martin, Neil ;
Davidson, Joyce E. ;
Cordeiro, Nuno ;
Oates, Bridget D. ;
Neven, Benedicte ;
Rice, Gillian I. ;
Crow, Yanick J. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (08) :844-846
[8]   Comparison of RT-qPCR and Nanostring in the measurement of blood interferon response for the diagnosis of type I interferonopathies [J].
Pescarmona, Remi ;
Belot, Alexandre ;
Villard, Marine ;
Besson, Laurie ;
Lopez, Jonathan ;
Mosnier, Isabelle ;
Mathieu, Anne-Laure ;
Lombard, Christine ;
Garnier, Lorna ;
Frachette, Cecile ;
Walzer, Thierry ;
Viel, Sebastien .
CYTOKINE, 2019, 113 :446-452